Overview
Alia Durrani is an Ophthalmologist in St. Louis, Missouri. Dr. Durrani is highly rated in 12 conditions, according to our data. Her top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, Retinal Detachment, and Vitrectomy.
Her clinical research consists of co-authoring 12 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- POS
- PPO
- EPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Pepose Vision Institute PC
Nancy Holekamp is an Ophthalmologist in Chesterfield, Missouri. Dr. Holekamp is highly rated in 22 conditions, according to our data. Her top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, and Vitrectomy.
Barnes-Jewish Hospital
Philip Custer is an Ophthalmologist in Saint Louis, Missouri. Dr. Custer is highly rated in 9 conditions, according to our data. His top areas of expertise are Entropion, Anophthalmia Plus Syndrome, Eyelid Drooping, Ptosis, and Trabeculectomy.
Levent Akduman is an Ophthalmologist in Godfrey, Illinois. Dr. Akduman is highly rated in 28 conditions, according to our data. His top areas of expertise are Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Detachment, and Vitrectomy.
Frequently Asked Questions about Dr. Alia Durrani
How do I make an appointment with Dr. Alia Durrani?
You can book an appointment with Dr. Alia Durrani by calling their office at 314-367-1181. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Alia Durrani a top-rated expert for Age-Related Macular Degeneration (ARMD)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Alia Durrani is classified as an Distinguished expert for Age-Related Macular Degeneration (ARMD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Alia Durrani specialize in?
While Dr. Alia Durrani is a Ophthalmology, they have specific expertise in Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Diabetic Retinopathy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Ophthalmology.
Does Dr. Alia Durrani participate in research or clinical trials?
Yes. Dr. Alia Durrani has published 12 articles and abstracts on conditions like Age-Related Macular Degeneration (ARMD). You can view a list of Dr. Alia Durrani's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Alia Durrani accept my insurance?
Dr. Alia Durrani accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 314-367-1181 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Age-Related Macular Degeneration (ARMD)Dr. Durrani isDistinguished. Learn about Age-Related Macular Degeneration (ARMD).
- Late-Onset Retinal DegenerationDr. Durrani isDistinguished. Learn about Late-Onset Retinal Degeneration.
- Advanced
- Adult-Onset Vitelliform Macular Dystrophy (AVMD)
- Diabetic RetinopathyDr. Durrani isAdvanced. Learn about Diabetic Retinopathy.
- EndophthalmitisDr. Durrani isAdvanced. Learn about Endophthalmitis.
- Geographic AtrophyDr. Durrani isAdvanced. Learn about Geographic Atrophy.
- NeuroretinitisDr. Durrani isAdvanced. Learn about Neuroretinitis.
- Retinal Artery OcclusionDr. Durrani isAdvanced. Learn about Retinal Artery Occlusion.
- Experienced
- Bietti Crystalline Dystrophy (BCD)Dr. Durrani isExperienced. Learn about Bietti Crystalline Dystrophy (BCD).
- Birdshot ChorioretinopathyDr. Durrani isExperienced. Learn about Birdshot Chorioretinopathy.
- CataractDr. Durrani isExperienced. Learn about Cataract.
- Central Serous ChorioretinopathyDr. Durrani isExperienced. Learn about Central Serous Chorioretinopathy.
- Choroid Plexus CarcinomaDr. Durrani isExperienced. Learn about Choroid Plexus Carcinoma.
- Cone DystrophyDr. Durrani isExperienced. Learn about Cone Dystrophy.